Obermatt
See Similar Stocks →

Demant

CPH:DEMANT · DK0060738599
Health Care Equipment & SuppliesLarge

360

25
EV / EBIT34
Price / Owner Earnings27
Owner Earnings Yield42
Dividend Yield1
Price/Sales41
EV / Gross Profit69
Price/Book18
Return on Capital71
Cash Return on Capital34
Return on Equity89
EBIT Margin65
Gross Profitability69
Cash Conversion85
Accruals5
Owner Earnings Margin44
Sales growth92
Profit Growth76
Long-Term EPS Growth67
Owner Earnings Growth20
Reinvestment96
Price momentum69
Debt load7
Refinancing47
Debt Payback6
Liquidity54
Analyst ratings44
Opinion Changes50
Price Target Upside4
Market mood29
Value Creation14/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Demant generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeCPSE
Employees2,281
Websitedemant.com
ISINDK0060738599
Last UpdateApr 2, 2026
Indices
OMX C20 (Denmark)
Themes
Health DiagnosticsEar Nose & Throat (ENT)Assistive TechnologyHealth CareMedicalMedical Device

Description

Demant A/S is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. Business Segments The company operates within several business segments that encompass a…

Analysis

Middle-of-the-road

Demant A/S is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 32.3× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 13% yearly growth; analysts expect 14%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is fragile. The company scores 14/20 on our value-creation score: strong value creator.

What to watch: The financial cushion is thinner than comfortable. A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
33
2023202420252026

All-time high

68

Oct 2025

All-time low

4

Jan 2025

Average rank

28

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
41
45
46
47
Price/Earnings
23
40
40
34
Price/Book
18
19
10
21
Dividend Yield
1
1
1
32
Value (overall)
7
30
19
29

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Demant with its peers
Sonova
VTX:SOON
51
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Smith & Nephew
LSE:SN.
86
CountryUK
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Medartis Holding
SWX:MED
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Straumann
VTX:STMN
40
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Ambu
CPH:AMBU B
77
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
IVF Hartmann
SWX:VBSN
68
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →